Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

Neuronal Adenosine A2A Receptors Are Critical Mediators of Neurodegeneration Triggered by Convulsions.

Canas PM, Porciúncula LO, Simões AP, Augusto E, Silva HB, Machado NJ, Gonçalves N, Alfaro TM, Gonçalves FQ, Araújo IM, Real JI, Coelho JE, Andrade GM, Almeida RD, Chen JF, Köfalvi A, Agostinho P, Cunha RA.

eNeuro. 2018 Dec 26;5(6). pii: ENEURO.0385-18.2018. doi: 10.1523/ENEURO.0385-18.2018. eCollection 2018 Nov-Dec.

2.

Adenosine A2A Receptors in the Rat Prelimbic Medial Prefrontal Cortex Control Delay-Based Cost-Benefit Decision Making.

Leffa DT, Pandolfo P, Gonçalves N, Machado NJ, de Souza CM, Real JI, Silva AC, Silva HB, Köfalvi A, Cunha RA, Ferreira SG.

Front Mol Neurosci. 2018 Dec 20;11:475. doi: 10.3389/fnmol.2018.00475. eCollection 2018.

3.

Glutamate-induced and NMDA receptor-mediated neurodegeneration entails P2Y1 receptor activation.

Simões AP, Silva CG, Marques JM, Pochmann D, Porciúncula LO, Ferreira S, Oses JP, Beleza RO, Real JI, Köfalvi A, Bahr BA, Lerma J, Cunha RA, Rodrigues RJ.

Cell Death Dis. 2018 Feb 20;9(3):297. doi: 10.1038/s41419-018-0351-1.

4.

Boosting brain glucose metabolism to fight neurodegeneration?

de Ceballos ML, Köfalvi A.

Oncotarget. 2017 Feb 28;8(9):14273-14274. doi: 10.18632/oncotarget.15131. No abstract available.

5.

Methamphetamine Induces Anhedonic-Like Behavior and Impairs Frontal Cortical Energetics in Mice.

Fonseca R, Carvalho RA, Lemos C, Sequeira AC, Pita IR, Carvalho F, Silva CD, Prediger RD, Jarak I, Cunha RA, Fontes Ribeiro CA, Köfalvi A, Pereira FC.

CNS Neurosci Ther. 2017 Feb;23(2):119-126. doi: 10.1111/cns.12649. Epub 2016 Oct 19.

PMID:
27762079
6.

Cannabis: A Treasure Trove or Pandora's Box?

Solymosi K, Köfalvi A.

Mini Rev Med Chem. 2017;17(13):1223-1291. doi: 10.2174/1389557516666161004162133. Review.

PMID:
27719666
7.

Hierarchical glucocorticoid-endocannabinoid interplay regulates the activation of the nucleus accumbens by insulin.

Pinheiro BS, Lemos C, Neutzling Kaufmann F, Marques JM, da Silva-Santos CS, Carvalho E, Mackie K, Rodrigues RJ, Cunha RA, Köfalvi A.

Brain Res Bull. 2016 Jun;124:222-30. doi: 10.1016/j.brainresbull.2016.05.009. Epub 2016 May 18.

PMID:
27208730
8.

Stimulation of brain glucose uptake by cannabinoid CB2 receptors and its therapeutic potential in Alzheimer's disease.

Köfalvi A, Lemos C, Martín-Moreno AM, Pinheiro BS, García-García L, Pozo MA, Valério-Fernandes Â, Beleza RO, Agostinho P, Rodrigues RJ, Pasquaré SJ, Cunha RA, de Ceballos ML.

Neuropharmacology. 2016 Nov;110(Pt A):519-529. doi: 10.1016/j.neuropharm.2016.03.015. Epub 2016 Mar 11.

9.

Caffeine Reverts Memory But Not Mood Impairment in a Depression-Prone Mouse Strain with Up-Regulated Adenosine A2A Receptor in Hippocampal Glutamate Synapses.

Machado NJ, Simões AP, Silva HB, Ardais AP, Kaster MP, Garção P, Rodrigues DI, Pochmann D, Santos AI, Araújo IM, Porciúncula LO, Tomé ÂR, Köfalvi A, Vaugeois JM, Agostinho P, El Yacoubi M, Cunha RA, Gomes CA.

Mol Neurobiol. 2017 Mar;54(2):1552-1563. doi: 10.1007/s12035-016-9774-9. Epub 2016 Feb 9.

PMID:
26860412
10.

Adenosine A2B receptor activation stimulates glucose uptake in the mouse forebrain.

Lemos C, Pinheiro BS, Beleza RO, Marques JM, Rodrigues RJ, Cunha RA, Rial D, Köfalvi A.

Purinergic Signal. 2015 Dec;11(4):561-9. doi: 10.1007/s11302-015-9474-3. Epub 2015 Oct 7.

11.

Lack of presynaptic interaction between glucocorticoid and CB1 cannabinoid receptors in GABA- and glutamatergic terminals in the frontal cortex of laboratory rodents.

Bitencourt RM, Alpár A, Cinquina V, Ferreira SG, Pinheiro BS, Lemos C, Ledent C, Takahashi RN, Sialana FJ, Lubec G, Cunha RA, Harkany T, Köfalvi A.

Neurochem Int. 2015 Nov;90:72-84. doi: 10.1016/j.neuint.2015.07.014. Epub 2015 Jul 18.

12.

Ketone bodies effectively compete with glucose for neuronal acetyl-CoA generation in rat hippocampal slices.

Valente-Silva P, Lemos C, Köfalvi A, Cunha RA, Jones JG.

NMR Biomed. 2015 Sep;28(9):1111-6. doi: 10.1002/nbm.3355. Epub 2015 Jul 15.

PMID:
26174755
13.

Adenosine A2b receptors control A1 receptor-mediated inhibition of synaptic transmission in the mouse hippocampus.

Gonçalves FQ, Pires J, Pliassova A, Beleza R, Lemos C, Marques JM, Rodrigues RJ, Canas PM, Köfalvi A, Cunha RA, Rial D.

Eur J Neurosci. 2015 Apr;41(7):878-88. doi: 10.1111/ejn.12851. Epub 2015 Feb 19.

PMID:
25704806
14.

Behavioral phenotyping of Parkin-deficient mice: looking for early preclinical features of Parkinson's disease.

Rial D, Castro AA, Machado N, Garção P, Gonçalves FQ, Silva HB, Tomé AR, Köfalvi A, Corti O, Raisman-Vozari R, Cunha RA, Prediger RD.

PLoS One. 2014 Dec 8;9(12):e114216. doi: 10.1371/journal.pone.0114216. eCollection 2014. Erratum in: PLoS One. 2015;10(3):e0118526.

15.

Presynaptic adenosine A2A receptors dampen cannabinoid CB1 receptor-mediated inhibition of corticostriatal glutamatergic transmission.

Ferreira SG, Gonçalves FQ, Marques JM, Tomé ÂR, Rodrigues RJ, Nunes-Correia I, Ledent C, Harkany T, Venance L, Cunha RA, Köfalvi A.

Br J Pharmacol. 2015 Feb;172(4):1074-86. doi: 10.1111/bph.12970. Epub 2015 Jan 12.

16.

Presynaptic TRPV1 vanilloid receptor function is age- but not CB1 cannabinoid receptor-dependent in the rodent forebrain.

Köles L, Garção P, Zádori ZS, Ferreira SG, Pinheiro BS, da Silva-Santos CS, Ledent C, Köfalvi A.

Brain Res Bull. 2013 Aug;97:126-35. doi: 10.1016/j.brainresbull.2013.06.007. Epub 2013 Jul 4.

PMID:
23831917
17.

Functional interaction between pre-synaptic α6β2-containing nicotinic and adenosine A2A receptors in the control of dopamine release in the rat striatum.

Garção P, Szabó EC, Wopereis S, Castro AA, Tomé ÂR, Prediger RD, Cunha RA, Agostinho P, Köfalvi A.

Br J Pharmacol. 2013 Aug;169(7):1600-11. doi: 10.1111/bph.12234.

18.

Presynaptic α₂-adrenoceptors control the inhibitory action of presynaptic CB₁ cannabinoid receptors on prefrontocortical norepinephrine release in the rat.

Richter H, Teixeira FM, Ferreira SG, Kittel Á, Köfalvi A, Sperlágh B.

Neuropharmacology. 2012 Oct;63(5):784-97. doi: 10.1016/j.neuropharm.2012.06.003. Epub 2012 Jun 18.

PMID:
22722024
19.

Presynaptic CB(1) cannabinoid receptors control frontocortical serotonin and glutamate release--species differences.

Ferreira SG, Teixeira FM, Garção P, Agostinho P, Ledent C, Cortes L, Mackie K, Köfalvi A.

Neurochem Int. 2012 Jul;61(2):219-26. doi: 10.1016/j.neuint.2012.05.009. Epub 2012 May 17.

20.

Caffeine regulates frontocorticostriatal dopamine transporter density and improves attention and cognitive deficits in an animal model of attention deficit hyperactivity disorder.

Pandolfo P, Machado NJ, Köfalvi A, Takahashi RN, Cunha RA.

Eur Neuropsychopharmacol. 2013 Apr;23(4):317-28. doi: 10.1016/j.euroneuro.2012.04.011. Epub 2012 May 4.

PMID:
22561003
21.

Impaired hippocampal glucoregulation in the cannabinoid CB1 receptor knockout mice as revealed by an optimized in vitro experimental approach.

Lemos C, Valério-Fernandes A, Ghisleni GC, Ferreira SG, Ledent C, de Ceballos ML, Köfalvi A.

J Neurosci Methods. 2012 Mar 15;204(2):366-73. doi: 10.1016/j.jneumeth.2011.11.028. Epub 2011 Dec 6.

PMID:
22155442
22.

CB₁ receptor activation inhibits neuronal and astrocytic intermediary metabolism in the rat hippocampus.

Duarte JM, Ferreira SG, Carvalho RA, Cunha RA, Köfalvi A.

Neurochem Int. 2012 Jan;60(1):1-8. doi: 10.1016/j.neuint.2011.10.019. Epub 2011 Nov 9.

PMID:
22085448
23.

Molecular reorganization of endocannabinoid signalling in Alzheimer's disease.

Mulder J, Zilberter M, Pasquaré SJ, Alpár A, Schulte G, Ferreira SG, Köfalvi A, Martín-Moreno AM, Keimpema E, Tanila H, Watanabe M, Mackie K, Hortobágyi T, de Ceballos ML, Harkany T.

Brain. 2011 Apr;134(Pt 4):1041-60. doi: 10.1093/brain/awr046.

24.

Functional identification of cell phenotypes differentiating from mice retinal neurospheres using single cell calcium imaging.

De Melo Reis RA, Schitine CS, Köfalvi A, Grade S, Cortes L, Gardino PF, Malva JO, de Mello FG.

Cell Mol Neurobiol. 2011 Aug;31(6):835-46. doi: 10.1007/s10571-011-9673-6. Epub 2011 Mar 17.

PMID:
21409522
25.

Diabetes induces early transient changes in the content of vesicular transporters and no major effects in neurotransmitter release in hippocampus and retina.

Baptista FI, Gaspar JM, Cristóvão A, Santos PF, Köfalvi A, Ambrósio AF.

Brain Res. 2011 Apr 6;1383:257-69. doi: 10.1016/j.brainres.2011.01.071. Epub 2011 Jan 28.

PMID:
21281613
26.

Cannabinoids inhibit the synaptic uptake of adenosine and dopamine in the rat and mouse striatum.

Pandolfo P, Silveirinha V, dos Santos-Rodrigues A, Venance L, Ledent C, Takahashi RN, Cunha RA, Köfalvi A.

Eur J Pharmacol. 2011 Mar 25;655(1-3):38-45. doi: 10.1016/j.ejphar.2011.01.013. Epub 2011 Jan 23.

PMID:
21266173
27.

Pre-synaptic adenosine A2A receptors control cannabinoid CB1 receptor-mediated inhibition of striatal glutamatergic neurotransmission.

Martire A, Tebano MT, Chiodi V, Ferreira SG, Cunha RA, Köfalvi A, Popoli P.

J Neurochem. 2011 Jan;116(2):273-80. doi: 10.1111/j.1471-4159.2010.07101.x. Epub 2010 Dec 2.

28.

N-acyldopamines control striatal input terminals via novel ligand-gated cation channels.

Ferreira SG, Lomaglio T, Avelino A, Cruz F, Oliveira CR, Cunha RA, Köfalvi A.

Neuropharmacology. 2009 Mar;56(3):676-83. doi: 10.1016/j.neuropharm.2008.12.001. Epub 2008 Dec 7.

PMID:
19101577
29.

Modification upon aging of the density of presynaptic modulation systems in the hippocampus.

Canas PM, Duarte JM, Rodrigues RJ, Köfalvi A, Cunha RA.

Neurobiol Aging. 2009 Nov;30(11):1877-84. doi: 10.1016/j.neurobiolaging.2008.01.003. Epub 2008 Mar 4.

PMID:
18304697
30.

Anandamide and NADA bi-directionally modulate presynaptic Ca2+ levels and transmitter release in the hippocampus.

Köfalvi A, Pereira MF, Rebola N, Rodrigues RJ, Oliveira CR, Cunha RA.

Br J Pharmacol. 2007 Jun;151(4):551-63. Epub 2007 Apr 16.

31.

Differential glutamate-dependent and glutamate-independent adenosine A1 receptor-mediated modulation of dopamine release in different striatal compartments.

Borycz J, Pereira MF, Melani A, Rodrigues RJ, Köfalvi A, Panlilio L, Pedata F, Goldberg SR, Cunha RA, Ferré S.

J Neurochem. 2007 Apr;101(2):355-63. Epub 2007 Jan 24.

32.

Increase of cannabinoid CB1 receptor density in the hippocampus of streptozotocin-induced diabetic rats.

Duarte JM, Nogueira C, Mackie K, Oliveira CR, Cunha RA, Köfalvi A.

Exp Neurol. 2007 Mar;204(1):479-84. Epub 2007 Jan 11.

PMID:
17222407
33.

CB1 receptor antagonism increases hippocampal acetylcholine release: site and mechanism of action.

Degroot A, Köfalvi A, Wade MR, Davis RJ, Rodrigues RJ, Rebola N, Cunha RA, Nomikos GG.

Mol Pharmacol. 2006 Oct;70(4):1236-45. Epub 2006 Jul 19.

34.

Lack of evidence for functional TRPV1 vanilloid receptors in rat hippocampal nerve terminals.

Köfalvi A, Oliveira CR, Cunha RA.

Neurosci Lett. 2006 Jul 31;403(1-2):151-6. Epub 2006 May 2.

PMID:
16672175
35.

Supersensitivity of P2X receptors in cerebrocortical cell cultures after in vitro ischemia.

Wirkner K, Köfalvi A, Fischer W, Günther A, Franke H, Gröger-Arndt H, Nörenberg W, Madarász E, Vizi ES, Schneider D, Sperlágh B, Illes P.

J Neurochem. 2005 Dec;95(5):1421-37.

36.

Involvement of cannabinoid receptors in the regulation of neurotransmitter release in the rodent striatum: a combined immunochemical and pharmacological analysis.

Köfalvi A, Rodrigues RJ, Ledent C, Mackie K, Vizi ES, Cunha RA, Sperlágh B.

J Neurosci. 2005 Mar 16;25(11):2874-84.

37.

P2X receptor activation elicits transporter-mediated noradrenaline release from rat hippocampal slices.

Papp L, Balázsa T, Köfalvi A, Erdélyi F, Szabó G, Vizi ES, Sperlágh B.

J Pharmacol Exp Ther. 2004 Sep;310(3):973-80. Epub 2004 Apr 14.

38.
39.

Involvement of P2X7 receptors in the regulation of neurotransmitter release in the rat hippocampus.

Sperlágh B, Köfalvi A, Deuchars J, Atkinson L, Milligan CJ, Buckley NJ, Vizi ES.

J Neurochem. 2002 Jun;81(6):1196-211.

40.
41.

Excessive release of [3H] noradrenaline by veratridine and ischemia in spinal cord.

Sumiya Y, Torigoe K, Gerevich Z, Köfalvi A, Vizi ES.

Neurochem Int. 2001 Jul;39(1):59-63.

PMID:
11311450
42.
43.

GABAergic interneurons are the targets of cannabinoid actions in the human hippocampus.

Katona I, Sperlágh B, Maglóczky Z, Sántha E, Köfalvi A, Czirják S, Mackie K, Vizi ES, Freund TF.

Neuroscience. 2000;100(4):797-804.

PMID:
11036213
44.

Cardioversion of atrial fibrillation with ibutilide in an orthotopic heart transplant patient.

Kaufman LJ, Kofalvi AE, Hong RA, Moreno-Cabral CE, Low LL.

J Heart Lung Transplant. 1999 Oct;18(10):1018-20. Review. No abstract available.

PMID:
10561113

Supplemental Content

Loading ...
Support Center